help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Caamano, J.
Right arrow Articles by Klein-Szanto, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caamano, J.
Right arrow Articles by Klein-Szanto, A. J.

American Journal of Pathology, Vol 142, 1131-1139, Copyright © 1993 by American Society for Investigative Pathology


REGULAR ARTICLES

p53 alterations in human squamous cell carcinomas and carcinoma cell lines

J Caamano, SY Zhang, EA Rosvold, B Bauer and AJ Klein-Szanto
Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA 19111.

p53 alterations were studied in a group of 22 primary squamous cell carcinomas (SCC) of the head and neck and in 10 cell lines derived from SCC. Positive immunohistochemical detection of p53 was accomplished in 10 of 22 primary tumors and in 7 of 10 SCC cell lines. Loss of heterozygosity of chromosome 17p, were the p53 gene is localized, was seen in five of seven SCC lines studied. DNA sequencing of the p53 gene of these five cell lines that had lost one allele showed p53 mutations in the remaining allele. In addition, from six primary SCC that exhibited loss of heterozygosity of chromosome 17p, three showed missense mutations of the p53 gene. The mutations of primary tumors and SCC cell lines were scattered in the midregion of the gene, affecting codons 151, 155, 174, 194, 220, 248, and 273. Five of these mutations modified guanine residues, a phenomenon that has been associated with the effect of carcinogens contained in tobacco smoke. Collectively these data show that approximately 50% of primary tumors and cell lines derived from SCC of the head and neck showed abnormalities of the p53 gene. In addition, it is of interest to note that the most invasive cell lines, as determined in an in vivo assay using xenotransplantation of tumor cells into denuded rat tracheal grafts, exhibited the most intense staining. Similarly, of five very advanced primary tumors, four showed intense p53 immunostain. These observations support the evidence that alterations in this tumor suppressor gene could be related to late events in tumor progression.


This article has been cited by other articles:


Home page
J. Dent. Res.Home page
S. Choi and J.N. Myers
Molecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for Therapy
J. Dent. Res., January 1, 2008; 87(1): 14 - 32.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Lopez de Cicco, D. E. Bassi, S. Zucker, N. G. Seidah, and A. J.P. Klein-Szanto
Human Carcinoma Cell Growth and Invasiveness Is Impaired by the Propeptide of the Ubiquitous Proprotein Convertase Furin
Cancer Res., May 15, 2005; 65(10): 4162 - 4171.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
O. Ashur-Fabian, A. Avivi, L. Trakhtenbrot, K. Adamsky, M. Cohen, G. Kajakaro, A. Joel, N. Amariglio, E. Nevo, and G. Rechavi
Evolution of p53 in hypoxia-stressed Spalax mimics human tumor mutation
PNAS, August 17, 2004; 101(33): 12236 - 12241.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. L. de Cicco, J. C. Watson, D. E. Bassi, S. Litwin, and A. J. Klein-Szanto
Simultaneous Expression of Furin and Vascular Endothelial Growth Factor in Human Oral Tongue Squamous Cell Carcinoma Progression
Clin. Cancer Res., July 1, 2004; 10(13): 4480 - 4488.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. J. Grille, A. Bellacosa, J. Upson, A. J. Klein-Szanto, F. van Roy, W. Lee-Kwon, M. Donowitz, P. N. Tsichlis, and L. Larue
The Protein Kinase Akt Induces Epithelial Mesenchymal Transition and Promotes Enhanced Motility and Invasiveness of Squamous Cell Carcinoma Lines
Cancer Res., May 1, 2003; 63(9): 2172 - 2178.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. E. Bassi, H. Mahloogi, R. Lopez De Cicco, and A. Klein-Szanto
Increased Furin Activity Enhances the Malignant Phenotype of Human Head and Neck Cancer Cells
Am. J. Pathol., February 1, 2003; 162(2): 439 - 447.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. E. Bassi, R. L. De Cicco, H. Mahloogi, S. Zucker, G. Thomas, and A. J. P. Klein-Szanto
Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cells
PNAS, August 17, 2001; (2001) 191199198.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S.-C. Liu, S. Y. Zhang, J. S. Babb, J. A. Ridge, and A. J. P. Klein-Szanto
Image Cytometry of Cyclin D1: A Prognostic Marker for Head and Neck Squamous Cell Carcinomas
Cancer Epidemiol. Biomarkers Prev., May 1, 2001; 10(5): 455 - 459.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. E. Bassi, R. Lopez De Cicco, H. Mahloogi, S. Zucker, G. Thomas, and A. J. P. Klein-Szanto
Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cells
PNAS, August 28, 2001; 98(18): 10326 - 10331.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American Society for Investigative Pathology.